logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

CeftazidimeAcquired drug resistance: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2025年 / 2042卷 / 1期
关键词:
D O I:
10.1007/s40278-025-74910-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:111 / 111
相关论文
共 50 条
  • [31] DaptomycinEmergence of drug resistance: case report
    Reactions Weekly, 2019, 1776 (1) : 150 - 150
  • [32] LevofloxacinAcquired drug resistance: case report
    Reactions Weekly, 2023, 1964 (1) : 252 - 252
  • [33] BevacizumabAcquired drug resistance: case report
    Reactions Weekly, 2016, 1602 (1) : 54 - 54
  • [34] LamivudineDevelopment of drug resistance: case report
    Reactions Weekly, 2019, 1758 (1) : 212 - 212
  • [35] NivolumabAcquired drug resistance: case report
    Reactions Weekly, 2019, 1757 (1) : 232 - 232
  • [36] BedaquilineDevelopment of drug resistance: case report
    Reactions Weekly, 2023, 1984 (1) : 109 - 109
  • [37] ErlotinibAcquired drug resistance: case report
    Reactions Weekly, 2025, 2049 (1) : 150 - 150
  • [38] KanamycinAcquired drug resistance: case report
    Reactions Weekly, 2019, 1765 (1) : 209 - 209
  • [39] GefitinibAcquired drug resistance: case report
    Reactions Weekly, 2020, 1833 (1) : 185 - 185
  • [40] PralsetinibAcquired drug resistance: case report
    Reactions Weekly, 2022, 1927 (1) : 451 - 451
← 12345 →